Sponsor:
UCLA
Code:
NCT02136784
Conditions
Analgesic Response
Eligibility Criteria
Sex: Male
Age: 20 - 50
Healthy Volunteers: Not accepted
Interventions
morphine sulfate
hydrocodone
hydromorphone HCI
oxycodone
buprenorphine
Brief summary:
Conditions
Analgesic Response
Study ID
NCT02136784
Start date
Apr, 2014
Status verified date
May, 2014
Completion date
Dec, 2014
Anticipated
Primary completion date
Dec, 2014
Anticipated
Eligibility Criteria
Sex: Male
Age: 20 - 50
Healthy Volunteers: Not accepted
Enrollment
12 participants
Anticipated
Allocation
Randomized
Intervention Model
Single group
Arms
experimental: morphine sulfate
experimental: hydrocodone
experimental: hydromorphone HCI
experimental: oxycodone
experimental: buprenorphine
placebo comparator: oral tablet placebo
placebo comparator: sublingual tablet placebo
Interventions
morphine sulfate
hydrocodone
hydromorphone HCI
oxycodone
buprenorphine
oral tablet placebo
sublingual tablet placebo
Primary outcome measure
Central contacts
Locations
UCLA Integrated Substance Abuse Programs Outpatient Clinical Research Center
Recruiting
Los Angeles, California, United States, 90025
Contacts
Principal Investigator:
Walter Ling, MD
Sponsor
University of California, Los Angeles
Last update posted
May 13, 2014
Last verified
May, 2014
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of California, Los Angeles on 2014-05-13.